인쇄하기
취소
|
The Korea Health Industry Development Institute(KHIDI) announced on the 10th it will support consulting expenses for medium and small pharmaceutical companies on R&D planning, licensing, approval and marketing.
Applicants of the program will be preliminary startups, ventures and small & medium companies in the Korean pharmaceutical and biotechnology fields, and KRW 30 million, at most, will be...